Company Search:
Advanced Search
Sponsored Links
Opgen Inc Company Snapshot
Opgen Inc operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Opgen Inc with three other pharmaceutical manufacturers in North America: Vermillion Inc (2018 sales of $3.05 million of which 100% was Novel Diagnostic Test), Core One Labs Inc of Canada (4.08 million Canadian Dollars [US$3.09 million] ), and Abeona Therapeutics Inc ($3.00 million of which 100% was Advanced Polymer).

Sales Analysis. Opgen Inc reported sales of $2.95 million for the year ending December of 2018. This represents a decrease of 8.2% versus 2017, when the company's sales were $3.21 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Opgen Inc
  Stock Performance Chart for Opgen Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/21/2020): 1.62
(Figures in U.S. Dollars)
1 Week -0.6%   13 Weeks -5.3%  
4 Weeks 27.6%   52 Weeks -94.4%  
Opgen Inc Key Data:
  Ticker: OPGN Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 2,946,307
(Year Ending Jan 2019).
Employees: 50
  Currency: U.S. Dollars Market Cap: 1,429,274
  Fiscal Yr Ends: December Shares Outstanding: 882,268
  Share Type: Common Closely Held Shares: 20,608
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.